WG
REGN icon

Wealth Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Wealth Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Buy
+400
New +$272K 0.06% 102
2024
Q4 		– Sell
-223
Closed -$234K – 162
2024
Q3 		$234K Sell
223
-1
-0.4% -$1.11K 0.16% 136
2024
Q2 		$235K Hold
224
– – 0.17% 134
2024
Q1 		$216K Buy
+224
New +$213K 0.16% 136

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Wealth Group's REGN Position: Q2 2026 in Review

Wealth Group opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 400 shares worth $249K. The stake represents 0.06% of the portfolio and ranks #102 among its holdings. This is a return to the name: Wealth Group previously reported a position in REGN as recently as Q3 2024.

Wealth Group first reported a position in REGN in Q1 2024 and has held it in 4 quarters since. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Wealth Group held 400 shares of Regeneron Pharmaceuticals worth $249K as of Q2 2026.
  • Regeneron Pharmaceuticals was a new Wealth Group position in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.06% of Wealth Group's portfolio in Q2 2026, its #102 holding.
  • Wealth Group first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Wealth Group's 13F filing for Q2 2026, filed 21 Jul 2026.